FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1898692666> ?p ?o ?g. }

• W1898692666 endingPage "4748" @default.
• W1898692666 startingPage "4741" @default.
• W1898692666 abstract "Experimental data suggest a complex cross-talk between HER-2 and estrogen receptor, and it has been hypothesized that HER-2-positive tumors may be less responsive to certain endocrine treatments. Clinical data, however, have been conflicting. We have conducted a meta-analysis on the interaction between the response to endocrine treatment and the overexpression of HER-2 in metastatic breast cancer.Studies have been identified by searching the Medline, Embase, and American Society of Clinical Oncology abstract databases. Selection criteria were (a) metastatic breast cancer, (b) endocrine therapy (any line of treatment), and (c) evaluation of HER-2 expression (any method). For each study, the relative risk for treatment failure for HER-2-positive over HER-2-negative patients with 95% confidence interval was calculated as an estimate of the predictive effect of HER-2. Pooled estimates of the relative risk were computed by the Mantel-Haenszel method.Twelve studies (n = 2,379 patients) were included in the meta-analysis. The overall relative risk was 1.42 (95% confidence interval, 1.32-1.52; P < 0.00001; test for heterogeneity = 0.380). For studies involving tamoxifen, the pooled relative risk was 1.33 (95% confidence interval, 1.20-1.48; P < 0.00001; test for heterogeneity = 0.97); for studies involving other hormonal drugs, a pooled relative risk of 1.49 (95% confidence interval, 1.36-1.64; P < 0.00001; test for heterogeneity = 0.08) was estimated. A second meta-analysis limited to tumors that were either estrogen receptor positive, estrogen receptor unknown, or estrogen receptor negative/progesterone receptor positive yielded comparable results.HER-2-positive metastatic breast cancer is less responsive to any type of endocrine treatment. This effect holds in the subgroup of patients with positive or unknown steroid receptors." @default.
• W1898692666 created "2016-06-24" @default.
• W1898692666 creator A5020128506 @default.
• W1898692666 creator A5025684262 @default.
• W1898692666 creator A5025725407 @default.
• W1898692666 creator A5028021994 @default.
• W1898692666 creator A5033560254 @default.
• W1898692666 creator A5034676299 @default.
• W1898692666 creator A5050215401 @default.
• W1898692666 creator A5056034569 @default.
• W1898692666 creator A5056639598 @default.
• W1898692666 creator A5064469497 @default.
• W1898692666 creator A5065889459 @default.
• W1898692666 creator A5068999228 @default.
• W1898692666 creator A5072257250 @default.
• W1898692666 creator A5078562748 @default.
• W1898692666 creator A5082076973 @default.
• W1898692666 creator A5089361418 @default.
• W1898692666 date "2005-07-01" @default.
• W1898692666 modified "2023-10-14" @default.
• W1898692666 title "A Meta-Analysis on the Interaction between HER-2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer" @default.
• W1898692666 cites W1601571585 @default.
• W1898692666 cites W1759102092 @default.
• W1898692666 cites W1813571362 @default.
• W1898692666 cites W1820219315 @default.
• W1898692666 cites W1901376003 @default.
• W1898692666 cites W1919801416 @default.
• W1898692666 cites W1922272927 @default.
• W1898692666 cites W1925485320 @default.
• W1898692666 cites W1976090068 @default.
• W1898692666 cites W1977221327 @default.
• W1898692666 cites W1978458095 @default.
• W1898692666 cites W1986335023 @default.
• W1898692666 cites W1990496960 @default.
• W1898692666 cites W1992843176 @default.
• W1898692666 cites W2005084132 @default.
• W1898692666 cites W2006720018 @default.
• W1898692666 cites W2016569614 @default.
• W1898692666 cites W2020612457 @default.
• W1898692666 cites W2037769103 @default.
• W1898692666 cites W2039969104 @default.
• W1898692666 cites W2040142253 @default.
• W1898692666 cites W2055961110 @default.
• W1898692666 cites W2057459166 @default.
• W1898692666 cites W2062713892 @default.
• W1898692666 cites W2074062119 @default.
• W1898692666 cites W2077252019 @default.
• W1898692666 cites W2084923342 @default.
• W1898692666 cites W2109388713 @default.
• W1898692666 cites W2114167623 @default.
• W1898692666 cites W2115581335 @default.
• W1898692666 cites W2123184189 @default.
• W1898692666 cites W2133408654 @default.
• W1898692666 cites W2141232624 @default.
• W1898692666 cites W2170832900 @default.
• W1898692666 cites W4252112751 @default.
• W1898692666 doi "https://doi.org/10.1158/1078-0432.ccr-04-2569" @default.
• W1898692666 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16000569" @default.
• W1898692666 hasPublicationYear "2005" @default.
• W1898692666 type Work @default.
• W1898692666 sameAs 1898692666 @default.
• W1898692666 citedByCount "306" @default.
• W1898692666 countsByYear W18986926662012 @default.
• W1898692666 countsByYear W18986926662013 @default.
• W1898692666 countsByYear W18986926662014 @default.
• W1898692666 countsByYear W18986926662015 @default.
• W1898692666 countsByYear W18986926662016 @default.
• W1898692666 countsByYear W18986926662017 @default.
• W1898692666 countsByYear W18986926662018 @default.
• W1898692666 countsByYear W18986926662019 @default.
• W1898692666 countsByYear W18986926662020 @default.
• W1898692666 countsByYear W18986926662021 @default.
• W1898692666 countsByYear W18986926662022 @default.
• W1898692666 countsByYear W18986926662023 @default.
• W1898692666 crossrefType "journal-article" @default.
• W1898692666 hasAuthorship W1898692666A5020128506 @default.
• W1898692666 hasAuthorship W1898692666A5025684262 @default.
• W1898692666 hasAuthorship W1898692666A5025725407 @default.
• W1898692666 hasAuthorship W1898692666A5028021994 @default.
• W1898692666 hasAuthorship W1898692666A5033560254 @default.
• W1898692666 hasAuthorship W1898692666A5034676299 @default.
• W1898692666 hasAuthorship W1898692666A5050215401 @default.
• W1898692666 hasAuthorship W1898692666A5056034569 @default.
• W1898692666 hasAuthorship W1898692666A5056639598 @default.
• W1898692666 hasAuthorship W1898692666A5064469497 @default.
• W1898692666 hasAuthorship W1898692666A5065889459 @default.
• W1898692666 hasAuthorship W1898692666A5068999228 @default.
• W1898692666 hasAuthorship W1898692666A5072257250 @default.
• W1898692666 hasAuthorship W1898692666A5078562748 @default.
• W1898692666 hasAuthorship W1898692666A5082076973 @default.
• W1898692666 hasAuthorship W1898692666A5089361418 @default.
• W1898692666 hasConcept C121608353 @default.
• W1898692666 hasConcept C126322002 @default.
• W1898692666 hasConcept C143998085 @default.
• W1898692666 hasConcept C2777176818 @default.
• W1898692666 hasConcept C44249647 @default.
• W1898692666 hasConcept C46699223 @default.
• W1898692666 hasConcept C530470458 @default.

• next